Provided by Tiger Fintech (Singapore) Pte. Ltd.

RAPT Therapeutics, Inc.

1.04
-0.0500-4.59%
Post-market: 1.02-0.0200-1.92%19:40 EDT
Volume:618.17K
Turnover:632.22K
Market Cap:137.58M
PE:-0.76
High:1.07
Open:1.07
Low:0.9900
Close:1.09
Loading ...

RAPT Therapeutics Announces 1-for-8 Reverse Stock Split Effective June 16, 2025

Reuters
·
13 Jun

RAPT Therapeutics Inc - Common Stock to Trade on Split-Adj Basis June 17, 2025

THOMSON REUTERS
·
13 Jun

RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split

THOMSON REUTERS
·
13 Jun

RAPT Therapeutics Announces Development Plans for RPT904

TIPRANKS
·
10 Jun

Rapt Therapeutics started at Buy at Clear Street on RPT904b opportunity

TIPRANKS
·
06 Jun

Rapt Therapeutics to Participate in Goldman Sachs 46th Annual Global Healthcare Conference

Reuters
·
05 Jun

Rapt Therapeutics Inc. Announces Approval of 2025 Equity Incentive Plan and Amended Employee Stock Purchase Plan

Reuters
·
30 May

RAPT Therapeutics Faces Nasdaq Delisting Notice

TIPRANKS
·
29 May

Rapt Therapeutics Inc. Announces Nasdaq Listing Rule Deficiency

Reuters
·
29 May

UBS Adjusts Price Target on RAPT Therapeutics to $1 From $2, Maintains Neutral Rating

MT Newswires Live
·
22 May

Rapt Therapeutics Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
22 May

RAPT Therapeutics Inc : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $6

THOMSON REUTERS
·
22 May

RAPT Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

RAPT Therapeutics Q1 EPS $(0.08) Beats $(0.14) Estimate

Benzinga
·
08 May

RAPT Therapeutics Inc: as of March 31, Had Cash and Cash Equivalents and Marketable Securities of $179.3 Mln

THOMSON REUTERS
·
08 May

RAPT Therapeutics Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
05 May

RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development

GlobeNewswire
·
15 Apr

RAPT Therapeutics Announces Board Restructuring in 2025

TIPRANKS
·
28 Mar

Analysts Conflicted on These Healthcare Names: Mind Medicine (MNMD), RAPT Therapeutics (RAPT) and LifeMD (LFMD)

TIPRANKS
·
11 Mar

RAPT Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
08 Mar